In 2015 Mylan had about $1.5 B in sales of EpiPens .
Those sales accounted for 40 % of Mylan 's profit .
In 2015 Mylan had about $1.5 B in sales of EpiPens and those sales accounted for 40 % of Mylan 's profit .